Colon to Rectum

Endoscopy. 2022;54(4):354–63

Taghiakbari M, Pohl H, Djinbachian R, Barkun A, Marques P, Bouin M, Deslandres E, Panzini B, Bouchard S, Weber A, von Renteln D

The location-based resect-and-discard strategy for diminutive colorectal polyps: A prospective clinical study


Background: Clinical implementation of the resect-and-discard strategy has been difficult because optical diagnosis is highly operator-dependent. This prospective study aimed to evaluate a resect-and-discard strategy that is not operator-dependent.
Methods: The study evaluated a resect-and-discard strategy that uses the anatomical polyp location to classify colonic polyps into non-neoplastic or low-risk neoplastic. All rectosigmoid diminutive polyps were considered hyperplastic and all polyps located proximally to the sigmoid colon were considered neoplastic. Surveillance interval assignments based on these a priori assumptions were compared with those based on actual pathology results and on optical diagnosis. The primary outcome was ≥ 90% agreement with pathology in surveillance interval assignment.
Results: 1117 patients undergoing complete colonoscopy were included and 482 (43.1%) had at least 1 diminutive polyp. Surveillance interval agreement between the location-based strategy and pathological findings using the 2020 US Multi-Society Task Force guideline was 97.0% (95% confidence interval [CI]: 0.96–0.98), surpassing the ≥ 90% benchmark. Optical diagnoses using the NICE and Sano classifications reached 89.1% and 90.01% agreement, respectively (p < 0.001), and were inferior to the location-based strategy. The location-based resect-and-discard strategy allowed a 69.7% (95% CI: 0.67–0.72) reduction in pathology examinations compared with 55.3% (95% CI: 0.52–0.58; NICE and Sano) and 41.9% (95% CI: 0.39–0.45; WASP) with optical diagnosis.

Conclusion: The location-based resect-and-discard strategy achieved very high surveillance interval agreement with pathology-based surveillance interval assignment, surpassing the ≥ 90% benchmark and outperforming optical diagnosis in surveillance interval agreement and the number of pathology examinations avoided.

Dr. M. Taghiakbari, Department of Medicine, Division of Gastroenterology, University of Montréal Hospital Center (CHUM) and University of Montréal Hospital Research Center (CRCHUM), Montréal, QC, Canada,
E-Mail: mahtakbar@gmail.com

DOI: DOI: 10.1055/a-1546-9169

Back to overview

this could be of interest:

Associations of body-mass index at different ages with early-onset colorectal cancer

Gastroenterology. 2022;162(4):1088–97.e3

Artificial intelligence and colonoscopy experience: Lessons from 2 randomized trials

Gut. 2022;71(4):757–65

More articles on the topic